Editorial policies
Overview
The journals published by Hamadan University of Medical Sciences endorse the guidelines of the Committee on Publication Ethics (COPE), the World Association of Medical Editors (WAME) Policy Statement on Geopolitical Intrusion on Editorial Decisions, the Council of Science Editors’ White Paper on Promoting Integrity in Scientific Journal Publications and the International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals.
Submitting
a manuscript to a journal published by Hamadan University of Medical
Sciences implies that all contributors listed as authors have read and
agreed to the content of the submitted work and that the submission
observes the policies of the journal.
Table of contents
- Ethics and consent
- Trial registration
- Standards of reporting
- Competing interests
- Authorship
- Unique identifiers
- Citations
- Duplicate publication
- Text recycling
- Peer review
- Confidentiality
- Misconduct
- Corrections and retractions
Ethics and consent
Ethics approval
The journals published by Hamadan University of Medical Sciences follow the guidelines of the Committee on Publication Ethics (COPE) and adhere to its Best Practice Guidelines.
Every
submission reporting a research must include a statement to verify that
ethics approval was sought for the study (or a statement that it was
not required and why), including the name of the ethics committee(s) or
institutional review board(s), the reference number/ID of the
approval(s), and a statement that participants gave informed consent
before participating. Even when a study has been approved by a research
ethics committee or institutional review board, editors may ask authors
for more detailed information about the ethics of the work. Also,
research involving human subjects, human tissue, or human data must have
been performed in accordance with the Declaration of Helsinki and
must have been approved by an appropriate ethics committee. Submissions
may be declined if the journals’ editors come to conclusion that a
research has not been carried out within an appropriate ethical
framework. The editors may also contact the institutions’ ethics
committee for further information in certain cases.
Allegations
of publication misconduct, both before and after publication will be
carefully inspected and we reserve the right to contact authors'
institutions, funders, or regulatory bodies if necessary. If a
conclusive evidence of misconduct is noticed, proper steps will be taken
to correct the scientific record, which may include supplying a
correction or retraction.
Authors
are assumed that they are aware of publication ethics, specifically
with regard to authorship, dual submission, plagiarism, figure
manipulation, competing interests and compliance with standards of
research ethics. In cases of suspected misconduct, COPE standards and
practices will be followed and advice from the COPE forum will be
ascertained.
Retrospective ethics approval
If
a study has not been granted ethics committee approval prior to
commencing, retrospective ethics approval usually cannot be obtained and
it may not be possible to consider the submission for peer review. The
decision on whether to proceed to peer review in such cases is at the
discretion of the journals’ editors.
Patient consent and confidentiality
Any
item submitted to the journals published by Hamadan University of
Medical Sciences that contains personal medical information about an
identifiable living individual requires patient’s explicit consent
before it can be published. Consequently; all studied patients are
required to sign an informed consent form after reading the studies’
information sheet.
If
consent cannot be obtained because the patient cannot be traced in a
study, then publication will be possible only if the information can be
sufficiently anonymized. Anonymization means that neither the person nor
anyone else could identify the individual with certainty.
If
the patient is dead the authors should seek permission from a relative
(as a matter of courtesy and medical ethics). If the relatives are not
contactable, the journals will balance the worthwhileness of the case,
the likelihood of identification, and the likelihood of offence in
decision to publish a submitted paper.
Images—such
as x-rays, laparoscopic images, ultrasound images, pathology slides, or
images of undistinctive parts of the body—may be used without consent
so long as they are anonymized by the removal of any identifying marks
and are not accompanied by text that could reveal the patients’
identity.
Research involving animals
Experimental
research on vertebrates or any regulated invertebrates must comply with
institutional, national, or international guidelines, and where
available should have been approved by an appropriate ethics committee.
The Basel Declaration outlines
fundamental principles to adhere when conducting research on animals
and the International Council for Laboratory Animal Science (ICLAS) has
also published ethical guidelines.
For
experimental studies involving client-owned animals, authors must also
document informed consent from the client or owner and adherence to a
high standard (best practice) of veterinary care.
Trial registration
Based on the ICMJE recommendations
a clinical trial is defined as “any research project that prospectively
assigns people or a group of people to an intervention, with or without
concurrent comparison or control groups, to study the cause-and-effect,
relationship between a health-related intervention and a health
outcome.”
In agreement with the ICMJE’s
recommendations, all journals published by Hamadan University of
Medical Sciences will not consider reports of clinical trials unless
they were registered prospectively before recruitment of any
participants.
As
a condition of consideration for publication, journals published by the
Hamadan University of Medical Sciences require registration of all
trials in a public registry of trials approved by the ICMJE (any
registry that is a primary register of the WHO International Clinical
Trials Registry Platformwww.who.int/ictrp/network/primary/en/index.html).
The trial registration number and the date of registration should be included in the last line of the submission abstract.
Standards of reporting
Authors are encouraged to use the relevant research reporting guidelines for the study type provided by the EQUATOR Network when
preparing their manuscript. Authors should adhere to these guidelines
when drafting their manuscript, and peer reviewers will be asked to
refer to these checklists when evaluating such studies. This will ensure
that the authors have provided enough information for editors, peer
reviewers, and readers to understand how the research was performed and
to judge whether the findings are likely to be reliable.
The key reporting guidelines are:
Statistical methods
Authors
are requested to include full information about the applied statistical
methods and measures in their research, including justification of the
appropriateness of the statistical test used (see the SAMPL guidelines for
more information). Reviewers will be asked to check the statistical
methods, and the submission may be sent for statistical review by
specialists if considered necessary. The editors may also consult a
specialist in the field of methodology.
Competing interests
A
competing interest is anything that interferes with, or could
reasonably be perceived as interfering with, the full and objective
presentation, peer review, editorial decision-making, or publication of
research or non-research articles submitted to the journals published by
Hamadan University of Medical Sciences.
A
competing interest exists when professional judgment concerning a
primary interest (such as patients’ welfare or the validity of research)
may be influenced by a secondary interest (such as financial
gain,—employment, consultancies, stock ownership or options, honoraria,
patents, and paid expert—testimony or personal relationship). There is
nothing unethical about a competing interest but it should be
acknowledged and clearly stated. All authors must declare all competing
interests in their covering letter and in the “competing interests”
section upon submission. Where authors have no competing interests, the
statement should read “The author(s) declare(s) that they have no
competing interests with regards to authorship and/or publication of
this article.” The Editor may ask for further information relating to
competing interests.
Editors
and reviewers are also required to declare any competing interests and
will be excluded from the peer review process if a competing interest
exists.
The
policy of Hamadan University of Medical Sciences is that none of the
journals’ editors should have any financial relationship with any
biomedical company.
Declaring
all potential competing interests is a requirement and is integral to
the transparent reporting of research. Failure to declare competing
interests can result in immediate rejection of a manuscript. If an
undisclosed competing interest comes to light after publication, Hamadan
University of Medical Sciences will take action in accordance with COPE
guidelines and issue a public notification to the community.
Competing
interests can be financial or non-financial, professional, or personal.
Competing interests can arise in relation to an organization or a
person.
Financial competing interests
Financial competing interests include (but are not limited to):
- Receiving
reimbursements, fees, funding, or salary from an organization that may
in any way gain or lose financially from the publication of the
manuscript, either now or in the future.
- Holding
stocks or shares in an organization that may in any way gain or lose
financially from the publication of the manuscript, either now or in the
future.
- Holding, or currently applying for patents relating to the content of the manuscript.
- Receiving
reimbursements, fees, funding or salary from an organization that holds
or has applied for patents relating to the content of the manuscript.
Non-financial competing interests
Non-financial
competing interests include (but are not limited to) political,
personal, ideological, academic, and intellectual competing interests.
Commercial organizations
Authors
from pharmaceutical companies, or other commercial organizations that
sponsor clinical trials, should declare these as competing interests on
submission. They should also adhere to the Good Publication Practice guidelines for pharmaceutical companies(GPP2),
which are designed to ensure that publications are produced in a
responsible and ethical manner. The guidelines also apply to any
companies or individuals that work on industry-sponsored publications,
such as freelance writers, contract research organizations and
communications companies. Hamadan University of Medical Sciences will
not publish advertorial content.
Authorship
An 'author' is generally considered to be someone who has made substantive intellectual contributions to a published study.
The ICMJE recommends that authorship be based on the following 4 criteria:
1. Substantial contributions to the conception or design of the work or the acquisition, analysis or interpretation of data.
2. Drafting the work or revising it critically for important intellectual content.
3. Final approval of the version published.
4.
Agreement to be accountable for all aspects of the work in ensuring
that questions related to the accuracy or integrity of any part of the
work are appropriately investigated and resolved.
In
addition to being accountable for the parts of the work the authors
have done, an author should be able to identify which co-authors are
responsible for specific other parts of the work. In addition, authors
should have confidence in the integrity of the contributions of their
coauthors. All those designated as authors should meet all four criteria
for authorship, and all who meet the four criteria should be identified
as authors.
Participation
solely in the acquisition of funding, gathering of the data, technical
help, writing assistance and general supervision of the research group
does not warrant authorship. Those individuals who do not meet all four
criteria should appear in the “Acknowledgments” section.
Acknowledgments
The
individuals who provided assistance to the submitted work, who do not
meet all four criteria of authorship, should be recognized by listing
their names and contribution in the “Acknowledgments” section. The
authors have to guarantee that anyone named in the “Acknowledgements”
section has granted its clearance for permission to be listed for the
stated contributions towards the work.
Financial
and material support should also be acknowledged. All sources of grant
and other support for the project or study, including funds received
from contributors, institutions and commercial sources are required to
be reported. Consultancies and funds paid directly to investigators must
also be listed. The involvement of scientific (medical) writers or
anyone else who assisted with the preparation of the manuscript content
should be acknowledged, along with their source of funding, as described
in the European Medical Writers Association (EMWA) guidelines.
Author information
Author
information is published by the journals so that the authors and their
institutes be recognizable for the scientific community. Author
information is also used to retrieve records in databases and
bibliographic indexes, and yet many databases either do not include or
do not list all author information. We recognize that some authors have
multi-part first, middle or last names and that some authors do not have
a middle name, but a part of their first or last name has been used
previously to provide a middle name initial in another publication. It
is the policy of the journals published by Hamadan University of Medical
Sciences to publish author information, including their names and
affiliations in the same format supplied by the corresponding author
upon submission. To ensure that publications have correct author
information, to avoid any errors regarding how a certain author name
should be spelled or supplied to bibliographic indexes and databases and
to keep changes in proofing of the articles or corrections after their
publication to a minimum, the authors submitting to the journals
published by the Hamadan University of Medical Sciences are required,
upon submission, to review and approve an automatically-generated
presentation of author information, as in a published record, based on
their provided information. This includes how author information will
appear in databases like PubMed or Scopus. Therefore, the authors should
enter their information in the provided submission area in a way that
is bibliographically consistent with their previous publications.
Authorship changes
Any
change in authorship (i.e. order, addition, and deletion of authors)
after initial submission must be approved by all authors. Authors should
determine and come to an agreement about the order of authorship among
themselves. In addition, any alterations must be clarified to the
editor. In line with COPE guidelines,
Hamadan University of Medical Sciences requires written confirmation
from all authors that they agree with any proposed changes in authorship
of submission(s) or published item(s). This confirmation must be via
direct email from each author. It is the corresponding author’s
responsibility to ensure that all authors confirm they agree with the
proposed changes. If there is disagreement amongst the authors
concerning authorship and a satisfactory agreement cannot be reached,
the authors must contact their institution(s) for a resolution. It is
not the journal editor’s responsibility to resolve authorship disputes. A
change in authorship of a published article can only be amended via
publication of an Erratum.
Unique identifiers
ORCID (Open
Researcher and Contributor ID) is an open, non-profit, community-based
effort to provide a registry of unique researcher identifiers and a
transparent method of linking research activities and outputs to these
identifiers. Scopus author
ID is another unique identifier. Hamadan University of Medical Sciences
encourages use of these unique identifiers to identify the individuals
who submit a work to the journals or those who are selected as reviewers
to undertake the peer-review of submissions for the journals. The
editorial team members of the journals also include their unique
identifiers in their profiles.
Citations
Research
articles and non-research articles (e.g. Opinion, Review, and
Commentary articles) must cite appropriate and relevant literature in
support of the claims made. Excessive and inappropriate self-citation or
coordinated efforts among several authors to collectively self-cite is
strongly discouraged.
Authors should consider the following guidelines when preparing their manuscript:
- Any
statement in the manuscript that relies on external sources of
information (i.e. not the authors' own new ideas or findings or general
knowledge) should use a citation.
- Authors
should avoid citing derivations of original work. For example, they
should cite the original work rather than a review article that cites an
original work.
- Authors
should ensure that their citations are accurate (i.e. they should
ensure the citation supports the statement made in their manuscript and
should not misrepresent another work by citing it if it does not support
the point the authors wish to make).
- Authors should not cite sources that they have not read.
- Authors should not preferentially cite their own or their friends’, peers’, or institution’s publications.
- Authors should avoid citing work solely from one country.
- Authors should not use an excessive number of citations to support one point.
- Ideally, authors should cite sources that have undergone peer review where possible.
- Authors should not cite advertisements or advertorial material.
Duplicate publication
Any
manuscript that is submitted to a journal published by Hamadan
University of Medical Sciences must be original and the manuscript or
substantial parts of it, must not be under consideration by any other
journal. In any case where there is the potential for overlap or
duplication we require authors to be transparent. Authors should declare
any potentially overlapping publications on submission and where
possible, upload these as additional files with the manuscript. Any
overlapping publications should be cited. Any ‘in press’ or unpublished
manuscript cited or relevant to the Editor’s and reviewers' assessment
of the manuscript, should be made available if requested by the Editor.
Hamadan University of Medical Sciences reserves the right to judge
potentially overlapping or redundant publications on a case-by-case
basis.
In
general, the submitted manuscript should not already have been formally
published in any journal or in any other citable form. If justified and
made clear upon submission, there are exceptions to this rule, such as
publication in the form of a poster or conference presentation.
The journals published by Hamadan University of Medical Sciences use CrossCheck’s
plagiarism detection technology and take seriously all cases of
publication misconduct. Any suspected cases of covert duplicate
manuscript submission will be handled as outlined in the COPE guidelines and
the Editor may contact the authors’ institution. Hamadan University of
Medical Sciences endorses the policies of the ICMJE in relation to overlapping publications.
Pre-print servers and author/institutional repositories
Posting a manuscript on a pre-print server such as ArXiv, BioRxiv, PeerJ PrePrints,
or similar platforms (both commercial and non-commercial) is not
considered to be duplicate publication. The journals published by
Hamadan University of Medical Sciences will also consider peer reviewing
manuscripts that have been posted on an author's personal or
institutional website. Material that has formed part of an academic
thesis and been placed in the public domain, as required by the awarding
institution, will also be considered by journals published by Hamadan
University of Medical Sciences.
Summary clinical trial results in public registries
Posting
of summary clinical trial results in publicly accessible databases is
generally not considered duplicate publication. Hamadan University of
Medical Sciences requires authors of manuscripts reporting clinical
trials to have registered their trial in a suitably accessible registry.
Text recycling
Authors
should be aware that replication of text from their own previous
publications is text recycling (also referred to as self-plagiarism) and
in some cases is considered unacceptable. Where overlap of text with
authors’ own previous publications is necessary or unavoidable,
duplication must always be reported transparently and be properly
attributed and be compliant with copyright requirements. If a submission
contains text that has been published elsewhere, authors should notify
the journal editors in the submission cover letter.
Peer review
All
research articles, and most other article types, published by the
journals of Hamadan University of Medical Sciences undergo a thorough
peer review process. This usually involves review by two independent
peer reviewers. Individual journals may differ in their peer review
processes. For an individual journal’s peer review policy, please see
the journal website.
Peer review policy
All
submissions to journals published by Hamadan University of Medical
Sciences are assessed by an editor, who will decide whether they are
suitable for peer review. Where an editor is on the author list or has
any other competing interest regarding a specific submission, another
member of the editorial board will be assigned to assume responsibility
for overseeing peer review. Submissions felt to be suitable for
consideration will be sent for peer review by appropriate independent
experts. Editors will make a decision based on the reviewers’ reports
and authors are sent these reports along with the editorial decision on
their manuscript. Authors should note that even in light of one positive
report, concerns raised by another reviewer may fundamentally undermine
the study and result in the manuscript being rejected.
All
journals published by Hamadan University of Medical Sciences operate a
closed double-blind peer review process. The authors and the reviewers
will be treated anonymously.
Peer reviewers
Authors
may suggest potential reviewers if they wish; however, decision to
consider these reviewers is at the editor's discretion. Authors should
not suggest recent collaborators or colleagues who work in the same
institution as themselves. Authors who wish to suggest peer reviewers
can do so in the cover letter and should provide institutional email
addresses where possible or information which will help the Editor to
verify and identity the potential introduced reviewer (for example an
ORCID or Scopus ID).
Authors may request exclusion of individuals as peer reviewers, but they
should explain the reasons in their cover letter on submission. Authors
should not exclude too many individuals as this may hinder the peer
review process. Please note that the editor may choose to invite
excluded peer reviewers.
Intentionally falsifying information, for example, suggesting reviewers
with a false name or email address, will result in rejection of the
manuscript and may lead to further investigation in line with our
misconduct policy.
Confidentiality
Editors
will treat all submission to their journal in confidence. Reviewers are
also required to treat manuscripts confidentially. Journals published
by Hamadan University of Medical Sciences will not share manuscripts
with third parties, except in cases of suspected misconduct. See
our Misconduct policy for further information.
Misconduct
Hamadan
University of Medical Sciences takes seriously all allegations of
potential misconduct. The journals published by Hamadan University of
Medical Sciences follow the COPE guidelines to deal with cases of suspected misconduct.
In
cases of suspected research or publication misconduct, it may be
necessary for the editor to contact and share manuscripts with third
parties, for example, author(s)’ institution(s) and ethics committee(s).
Hamadan University of Medical Sciences may also seek advice from COPE and discuss anonymized cases in the COPE Forum.
Research misconduct
All
research involving humans (including human data and human material) and
animals must have been carried out within an appropriate ethical. If
there is suspicion that research has not taken place within an
appropriate ethical framework, the editor may reject a manuscript and
may inform third parties, for example, author(s)’ institution(s) and
ethics committee(s).
In
cases of proven research misconduct involving published articles, or
where the scientific integrity of the article is significantly
undermined, articles may be retracted.
Publication misconduct
All journals published by Hamadan University of Medical Sciences will follow the COPE guidelines to deal with cases of potential publication misconduct.
Image manipulation
- All
digital images in manuscripts considered for publication will be
scrutinized for any indication of manipulation that is inconsistent with
the following guidelines. Manipulation that violates these guidelines
may result in delays in manuscript processing or rejection, or
retraction of a published article.
- No specific feature within an image may be enhanced, obscured, moved, removed, or introduced.
- The
grouping of images from different parts of the same gel or from
different gels, fields or exposures must be made explicit by the
arrangement of the figure (i.e. using dividing lines) and in the text of
the figure legend.
- Adjustments
of brightness, contrast, or color balance are acceptable if they are
applied to every pixel in the image and as long as they do not obscure,
eliminate or misrepresent any information present in the original,
including the background. Non-linear adjustments (e.g. changes to gamma
settings) must be disclosed in the figure legend.
Any
questions raised during or after the peer review process will be
referred to the editor, who will request the original data from the
author(s) for comparison with the prepared figures. If the original data
cannot be produced, the submission may be rejected or in the case of a
published article, retracted. Any case in which the manipulation affects
the interpretation of the data will result in rejection or retraction.
Cases of suspected misconduct will be reported to the author(s)’
institution(s).
Plagiarism
Journals
published by Hamadan University of Medical Sciences use iThenticate
software, which is a plagiarism detector service that verifies the
originality of the submission content before publication. If plagiarism
is identified, we will follow COPE guidelines.
Plagiarism includes, but is not limited to:
- Directly copying text from other sources
- Copying ideas, images, or data from other sources
- Reusing text from your own previous publications
- Using an idea from another source with slightly modified language
If
plagiarism is detected during the peer review process, the submission
may be rejected. If plagiarism is detected after publication, we reserve
the right to issue a correction or retract the paper, as appropriate.
We reserve the right to inform authors' institutions about plagiarism
detected either before or after publication.
Corrections and retractions
Rarely,
it may be necessary for Hamadan University of Medical Sciences to
publish corrections to or retractions of articles published in its
journals to maintain the integrity of the academic record.
In
line with accepted norms of the academic community, corrections to, or
retractions of published articles will be made by publishing an Erratum
or a Retraction article, without altering the original article in any
way other than to add a prominent link to the Erratum/Retraction
article. The original article remains in the public domain and the
subsequent Erratum or Retraction will be widely indexed. In the
exceptional event that material is considered to infringe certain rights
or is defamatory, we may have to remove that material from our site and
archive sites.
It
may be possible for minor corrections to published articles to be made
by the original author(s) posting a comment on the published article.
This would only be appropriate where the changes do not affect the
results or conclusions of the article.
Corrections
Changes
to published articles that affect the interpretation and conclusion of
the article, but do not fully invalidate the article, will, at the
editor(s)’ discretion, be corrected via publication of an Erratum that
is indexed and linked to the original article. Changes in authorship of
published articles are corrected via an Erratum.
Retractions
On
rare occasions, when the scientific information in an article is
substantially undermined, it may be necessary for published articles to
be retracted. Hamadan University of Medical Sciences will follow the COPE guidelines in such cases. Retracted articles are indexed and linked to the original article.
|